🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨 Last chance to register for our one-of-a-kind event to celebrate #immunology within the wider #LifeSciences! Join us tomorrow to hear from world-class speakers, build your network & celebrate the inaugural #BSIImmunologyAwards ✨ Book your place now! bit.ly/3JunvhO

We are excited to share our latest paper Cell Press on RECOVER which was co-led by our CIO Jake Taylor-King Jake P. Taylor-King and Yoshua Bengio Mila - Institut québécois d'IA   #cause2cure #patientiswaiting lnkd.in/eQXacmWS

Interrogating LLMs for causal bio pathways may be a new frontier in discovering future cures. Relation Tx (disclosure: I cofounded & chair) just announced an amazing syndicate of investors to complete the $60M Seed: DCVC, Deerfield, NVIDIA, Magnetic. EndPts exclusive below👇.

Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm uk.finance.yahoo.com/news/relation-…

Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm | BioSpace biospace.com/article/releas… #jobs

Many thanks to Anthony Costa for his excellent chairing. It was a great pleasure to be part of this panel at #GTC24, along with my co-panelist Luca Naef Daphne Koller and Gary Glick on behalf of Relation.

AI & Biology/medicine is at its best time 🔥🔥exciting time ahead!

Many thanks Dr Emma S Chambers for an impactful 6 years of your time at the BSI Board, representing the Early Career Researchers along with Calum Bain Calum Bain inviting us to consider new approaches to support those at the start of their careers in Immunology. #BSI

May is #OsteoporosisAwareness month. At Relation, we use our Large Language Model & high dimensional patient data to shine a bright light on the mechanisms that underpin disease in these underserved patients. Our aim is to develop novel therapeutics. #ThePatientIsWaiting

Have you ever wondered which single cell/spatial omic technology to use? There's lots of methods developed in academia, but no review of marketed products. Check the scTrends.org (sctrends.org) commentary in Nature Biotechnology by Jake P. Taylor-King & Adam Cribbs

LAST CHANCE to secure reduced registration fees for BSI #ImmuneTherapies24 ⏰ This event will bring together #clinical, academic and #industry thought leaders including keynote speaker Dr Dr. Paul Peter Tak 🌟 Don't miss out! Register TODAY (31 Oct) 🔗bit.ly/4eYp306

Looking forward to Paul Peter’s keynote lecture today and the Immune Therapies Summit #ImmuneTherapies24 British Society for Immunology

Looking forward to seeing you NeurIPS Conference with my colleagues from Relation Lindsay Edwards, Hagen Triendle, Anna Gogleva, and Rosie Rodriguez. Lindsay Edwards Hagen Triendl

Brilliant news! ⁦Relation⁩ linkedin.com/posts/edith-he…

In likely the largest deal ever for a seed-stage biotech/techbio company, DCVC-backed Relation and GSK will seek to create a new gen of drugs for fibrotic disease and osteoarthritis. Big congrats to both companies! More from DCVC GP Jason Pontin 👇 bit.ly/3ZunHo3

Incredibly delighted to be part of the Kennedy Trust Board. The high quality work and people funded by the trust paves the way to new therapeutic opportunities for patients! The Kennedy Trust for Rheumatology Research Kennedy Institute of Rheumatology

🧬 Relation partners with GSK to tackle fibrotic #diseases and osteoarthritis – advancing drug discovery for millions in need ➡️ ow.ly/fu1550UpZxv Their cutting-edge platform and GSK’s expertise aim to deliver transformative #medicines.

Great work from the Zou Lab - a truly AI-designed molecule against S. aureus James Zou #MRSA #AgenticAI

Many congratulations to my teo colleagues, so well-deserved Prof Deborah Dunn-Walters Deborah Dunn-Walters 💙 and Prof Clare Bryant Clare Bryant ([email protected]) 🚀🚀

🚨 A new £50M Medical Research Council Centre at UoM Biology, Medicine and Health and University of Oxford will explore how pollution, microbes & other environmental exposures rewire our immune system and cause chronic inflammatory diseases. sites.manchester.ac.uk/lydia-becker-i…